inositol has been researched along with alpha-synuclein in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 10 (71.43) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, Z; Cook, LJ; Cordenier, A; Floto, RA; Imarisio, S; Pasco, M; Rubinsztein, DC; Sarkar, S | 1 |
| Emmanouilidou, E; Stefanis, L; Vekrellis, K; Xilouri, M | 1 |
| Langston, JW; Manning-Boğ, AB; Schüle, B | 1 |
| Grabowski, GA; Quinn, B; Ran, H; Sun, Y; Witte, D; Xu, YH | 1 |
| Goldin, E; Gruschus, JM; Lee, JC; Moaven, N; Sidransky, E; Velayati, A; Westbroek, W; Yap, TL | 1 |
| Dermentzaki, G; Dimitriou, E; Michelakakis, H; Stefanis, L; Xilouri, M | 1 |
| Brown, ME; Hasan, S; Lai, AY; Lan, CP; McLaurin, J | 1 |
| Akbarian, S; Chou, VP; Ginns, EI; Guo, Y; Karlgren, J; Ko, N; LaMarca, ML; Lim, A; Mak, SK; Manning-Boğ, AB; Samuelsson, S; Vazquez-DeRose, J | 1 |
| Grabowski, GA; Li, RH; Liou, B; Quinn, B; Setchell, KD; Sun, Y; Witte, D; Xu, K; Xu, YH; Xue, L; Zhang, W | 1 |
| Beagan, J; Brown, E; Cao, H; Graham, AR; Hallett, PJ; Hayes, MA; Isacson, O; Izen, SC; McLean, JR; Park, E; Perez-Torres, E; Rocha, EM; Smith, GA | 1 |
| Ibrahim, T; McLaurin, J | 1 |
| Antoniadou, I; Arianoglou, G; Emmanouilidou, E; Karachaliou, A; Nikolopoulou, G; Papadopoulos, VE; Sardi, SP; Stefanis, L; Vekrellis, K | 1 |
| Chan, MY; Svenningsson, P; Zurbruegg, M | 1 |
| Aivazidis, S; Burbidge, KJ; Fredriksen, K; Gelyana, E; Mazzulli, JR; Pitcairn, C; Sharma, K; Zunke, F | 1 |
14 other study(ies) available for inositol and alpha-synuclein
| Article | Year |
|---|---|
Lithium induces autophagy by inhibiting inositol monophosphatase.
Topics: alpha-Synuclein; Animals; Autophagy; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Enzyme Inhibitors; Humans; Huntingtin Protein; Inositol; Lithium; Mutation; Nerve Tissue Proteins; Nuclear Proteins; Phosphoric Monoester Hydrolases; Protein Kinases; Sirolimus; TOR Serine-Threonine Kinases | 2005 |
Inducible over-expression of wild type alpha-synuclein in human neuronal cells leads to caspase-dependent non-apoptotic death.
Topics: alpha-Synuclein; Amino Acid Chloromethyl Ketones; Apoptosis; bcl-X Protein; Caspases; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Enzyme Inhibitors; Gene Expression Regulation; Green Fluorescent Proteins; Humans; Inositol; Membrane Potential, Mitochondrial; Mitochondria; Neuroblastoma; Staurosporine; Time Factors; Transfection; Tretinoin | 2009 |
Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism.
Topics: alpha-Synuclein; Analysis of Variance; Animals; Cell Differentiation; Disease Models, Animal; Dose-Response Relationship, Drug; Gaucher Disease; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Humans; Inositol; Mice; Mice, Inbred C57BL; Neuroblastoma; RNA, Messenger; Substantia Nigra | 2009 |
Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models.
Topics: Age Factors; alpha-Synuclein; Animals; beta-Glucosidase; Brain; Disease Models, Animal; Gaucher Disease; Glucosylceramides; Inclusion Bodies; Inositol; Mice; Mutation, Missense; Phenotype; Psychosine; Ubiquitin | 2011 |
Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases.
Topics: alpha-Synuclein; Amino Acid Substitution; Cell Line, Tumor; Enzyme Inhibitors; Gaucher Disease; Glucosylceramidase; Humans; Hydrogen-Ion Concentration; Inositol; Lysosomes; Multiprotein Complexes; Mutation, Missense; Parkinson Disease | 2011 |
Loss of β-glucocerebrosidase activity does not affect alpha-synuclein levels or lysosomal function in neuronal cells.
Topics: alpha-Synuclein; Animals; Autophagy; Cell Differentiation; Cell Line; Gaucher Disease; Glucosylceramidase; Humans; Inositol; Lysosomes; Neurons; Parkinson Disease; Protein Multimerization; Rats | 2013 |
scyllo-Inositol promotes robust mutant Huntingtin protein degradation.
Topics: alpha-Synuclein; Amyloid beta-Peptides; Animals; Huntingtin Protein; Inositol; Lysosomes; Mutation; Nerve Tissue Proteins; Nuclear Proteins; PC12 Cells; Peptides; Proteasome Endopeptidase Complex; Proteolysis; Rats | 2014 |
Neuroinflammation and α-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction.
Topics: alpha-Synuclein; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Evoked Potentials, Motor; Female; Gaucher Disease; Glucosylceramidase; Humans; Inflammation; Inositol; Male; Mice; MicroRNAs; Mutation; Neuronal Plasticity; Parkinson Disease; Synapses; Synaptic Transmission | 2014 |
Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice.
Topics: alpha-Synuclein; Amyloid beta-Protein Precursor; Animals; beta-Glucosidase; Cells, Cultured; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Enzyme Inhibitors; Gaucher Disease; Gene Expression Regulation; Hippocampus; Humans; Inositol; Lysosomal Membrane Proteins; Membrane Transport Proteins; Mice; Microtubule-Associated Proteins; Mitochondria; Mitochondrial Proteins; Neurons; Prostaglandin-Endoperoxide Synthases; Protein Aggregation, Pathological; Substantia Nigra | 2014 |
Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice.
Topics: alpha-Synuclein; Animals; Autophagy; Axonal Transport; Cerebral Cortex; Complement Activation; Complement C1q; Glucosylceramidase; Inositol; Male; Mice; Microglia; Parkinson Disease, Secondary; Protein Aggregation, Pathological; Proteins; Synaptic Transmission | 2015 |
α-Synuclein aggregation, seeding and inhibition by scyllo-inositol.
Topics: alpha-Synuclein; Animals; Binding Sites; Inositol; Mice; Multiprotein Complexes; Protein Binding; Species Specificity | 2016 |
Modulation of β-glucocerebrosidase increases α-synuclein secretion and exosome release in mouse models of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Brain; Disease Models, Animal; Exosomes; Glucosylceramidase; Humans; Inositol; Lysosomes; Mice; Mutation; Parkinson Disease | 2018 |
GBA RNAi but not catalytic inhibition of glucocerebrosidase with Conduritol-β-epoxide increases levels of total α-synuclein in SH-SY5Y cells.
Topics: alpha-Synuclein; Animals; Cell Line, Tumor; Cerebral Cortex; Glucosylceramidase; Humans; Inositol; Neurons; Rats; Rats, Wistar; RNA Interference | 2019 |
Pathological α-syn aggregation is mediated by glycosphingolipid chain length and the physiological state of α-syn in vivo.
Topics: alpha-Synuclein; Amino Acid Sequence; Animals; Brain; Cathepsins; Cell Differentiation; Glycosphingolipids; Humans; Induced Pluripotent Stem Cells; Inositol; Lysosomes; Mice; Time Factors | 2021 |